RNAi Pharmacokinetics - Protein Synthesis

Altered Methylprednisolone Pharmacodynamics in Healthy Subjects With Histamine N-Methyltransferase C314T Genetic Polymorphism
Altered Methylprednisolone Pharmacodynamics in Healthy Subjects With Histamine N-Methyltransferase C314T Genetic Polymorphism Apr 2006 Yuen Yi Hon, William J. Jusko, Vicky E. Spratlin, and Michael
Ascending Multiple-Dose Pharmacokinetics of Viramidine, a Prodrug of Ribavirin, in Adult Subjects With Compensated Hepatitis C Infection
Ascending Multiple-Dose Pharmacokinetics of Viramidine, a Prodrug of Ribavirin, in Adult Subjects With Compensated Hepatitis C Infection Mar 2005 Sanjee Aora, Christine Xu, Alice Teng, Janet Peter
Association of CYP2C8, CYP3A4, CYP3A5, and ABCB1 Polymorphisms with the Pharmacokinetics of Paclitaxel
Association of CYP2C8, CYP3A4, CYP3A5, and ABCB1 Polymorphisms with the Pharmacokinetics of Paclitaxel Nov 2005 Anja Henningsson, Sharon Marsh, Walter J. Loos, Mats O. Karlsson, Adam Garsa, Klaus
Challenges and opportunities of pharmacogenetics in drug development
Challenges and opportunities of pharmacogenetics in drug development May 2006 Ruth March Future Medicine Drugs fail the regulatory process for a variety of reasons, including issues with pharmac
Discordance Between N-acetyltransferase 2 Phenotype and Genotype in a Population of Hmong Subjects
Discordance Between N-acetyltransferase 2 Phenotype and Genotype in a Population of Hmong Subjects Jul 2006 Robert J. Straka, R. Todd Burkhardt, Nicholas P. Lang, Kelly Z. Hadsall, and Michael Y.
Evaluation of the Drug Interaction Potential of Aplaviroc, a Novel Human Immunodeficiency Virus Entry Inhibitor, Using a Modified Cooperstown 5 + 1 Cocktail
Evaluation of the Drug Interaction Potential of Aplaviroc, a Novel Human Immunodeficiency Virus Entry Inhibitor, Using a Modified Cooperstown 5 + 1 Cocktail May 2006 Brendan M. Johnson, Ivy H. Son
G2677T and C3435T Genotype and Haplotype Are Associated With Hepatic ABCB1 (MDR1) Expression
G2677T and C3435T Genotype and Haplotype Are Associated With Hepatic ABCB1 (MDR1) Expression Mar 2006 Pengfei Song, Jatinder K. Lamba, Lijun Zhang, Erin Schuetz, Nikhil Shukla, Bernd Meibohm, and
Pharmacokinetic and Pharmacodynamic Analysis of Amprenavir-Containing Combination Therapy in HIV-1-Infected Children
Pharmacokinetic and Pharmacodynamic Analysis of Amprenavir-Containing Combination Therapy in HIV-1-Infected Children Nov 2004 Daniel S. Stein, Yu Lou, Mark Johnson, Sharon Randall, Stephane Blanch
Pharmacokinetics of Paclitaxel in Ovarian Cancer Patients and Genetic Polymorphisms of CYP2C8, CYP3A4, and MDR1
Pharmacokinetics of Paclitaxel in Ovarian Cancer Patients and Genetic Polymorphisms of CYP2C8, CYP3A4, and MDR1 Jun 2005 Miki Nakajima, Yuto Fujiki, Satoru Kyo, Taro Kanaya, Mitsuhiro Nakamura, Yo
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of an Orally Active Novel Camptothecin Analog, DRF-1042, in Refractory Cancer Patients in a Phase I Dose Escalation Study
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of an Orally Active Novel Camptothecin Analog, DRF-1042, in Refractory Cancer Patients in a Phase I Dose Escalation Study Jul 2004 Aran
The Effect of Oral Pleconaril on Hepatic Cytochrome P450 3A Activity in Healthy Adults Using Intravenous Midazolam as a Probe
The Effect of Oral Pleconaril on Hepatic Cytochrome P450 3A Activity in Healthy Adults Using Intravenous Midazolam as a Probe Jan 2006 Joseph D. Ma, Anne N. Nafziger, Gerry Rhodes, Siyu Liu, Anne
The Effects of Ergoloid Mesylates and Ginkgo Biloba on the Pharmacokinetics of Ticlopidine
The Effects of Ergoloid Mesylates and Ginkgo Biloba on the Pharmacokinetics of Ticlopidine Jun 2006 Wen-Jen Lu, Jin-ding Huang, and Ming-Liang Lai Journal of Clinical Pharmacology Abstract Ticl